Marco E. Turini
Lugano, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 10, 2023
Micronutrient intakes in the Dutch diet: foods, fortified foods and supplements in a cross sectional study.
Journal: European journal of nutrition
Published: February 28, 2023
Prior Bexarotene or Phototherapy Does Not Affect Response to Chlormethine Gel: Post Hoc Analysis of a Pivotal Trial.
Journal: Acta dermato-venereologica
Published: October 18, 2022
Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study.
Journal: Dermatology and therapy
Published: August 25, 2022
Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspective.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 13, 2021
Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description.
Journal: Drugs in context
Published: April 17, 2020
Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 21, 2019
Factors Associated with Breastfeeding Initiation and Continuation: A Meta-Analysis.
Journal: The Journal of pediatrics
Published: January 19, 2018
NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK.
Journal: Drugs in context
Published: June 03, 2016
An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries.
Journal: Drugs in context
Published: June 30, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026